Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ROIV · as of Jun 8, 2026
Key Statistics
Explore Roivant Sciences Ltd. Data
roiv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 93.3%
The ROIV analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $37.17, representing +30.06% upside from the current price of $28.58.
Competitors & Peers
roiv competitorsROIV
ASND
BBIO
EXAS
IONS
JAZZStock Performance
Full HistoryAbout Roivant Sciences Ltd.
Roivant Sciences Ltd. a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, …
what is roivant sciences ltd. · roiv stock overview · roivant sciences ltd. company profile · who is roivant sciences ltd. ceo · roiv NASDAQ · roivant sciences ltd. headquarters · roivant sciences ltd. business segments
About Stock Overview & Key Data
Roivant Sciences Ltd. (ROIV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 8, 2020. As of the latest trading session, ROIV stock price is $28.58, with a market capitalization of $20.6B. The stock has returned +157.94% over the past 12 months and +31.71% year-to-date.
According to 15 Wall Street analysts, the consensus rating for Roivant Sciences Ltd. stock is Buy, with an average 12-month price target of $37.17. In fiscal year 2026, Roivant Sciences Ltd. reported revenue of $8.3M and net income of -$299.8M. For detailed data — including Roivant Sciences Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Roivant Sciences Ltd. (ROIV) stock price is $28.58. The stock is traded on NASDAQ under the ticker symbol ROIV. The 52-week range is $10.71 – $32.79.